News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
AngioDynamics Q3 Profit Edges Past Estimates
April 1, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- AngioDynamics Inc's (ANGO.O) quarterly profit scraped past market estimates, helped mainly by higher sales at its oncology/surgery and peripheral vascular businesses, and backed its full-year outlook.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Opinion
Biotechs Must Face Reality To Succeed in Today’s Funding Environment
March 24, 2026
·
5 min read
·
Ali Pashazadeh
Business
Tang Seizes Control of Aurinia, Taking CEO Post in Total Transformation of C-Suite
March 23, 2026
·
2 min read
·
Nick Paul Taylor
Funding
Backed by Sanofi, Pfizer, Earendil Bags $787M for AI-Driven Biologics Design
March 23, 2026
·
2 min read
·
Tristan Manalac
Parkinson’s disease
Oryon Splashes Onto Parkinson’s Scene With $42M for Cell Therapy
March 23, 2026
·
2 min read
·
Tristan Manalac
